methylprednisolone has been researched along with 4-aminopyridine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Nockels, R; Young, W | 1 |
Adelstein, EH; Haghighi, SS; Madsen, R; Perez-Espejo, MA | 1 |
Ducker, TB; Ellenbogen, RG; Ling, GS; Zeidman, SM | 1 |
Clapper, A; Haghighi, SS; Johnson, GC; Prapaisilp, A; Stevens, A | 1 |
Wickelgren, I | 1 |
Güneş, P; Külekçi Öztürk, S; Toraman, M; Uslu Coşkun, B | 1 |
Amini Harandi, A; Ilkhani, S; Karamiani, F; Mohammadi, F; Pakdaman, H; Sahraian, M; Shirzadeh Barough, S; Siavoshi, F | 1 |
2 review(s) available for methylprednisolone and 4-aminopyridine
Article | Year |
---|---|
Pharmacologic strategies in the treatment of experimental spinal cord injury.
Topics: 4-Aminopyridine; Animals; Baclofen; Disease Models, Animal; Gangliosides; Humans; Lipid Peroxidation; Methylprednisolone; Spinal Cord Injuries | 1992 |
Clinical applications of pharmacologic therapies for spinal cord injury.
Topics: 4-Aminopyridine; Animals; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Free Radical Scavengers; G(M1) Ganglioside; Glucocorticoids; Humans; Methylprednisolone; Multicenter Studies as Topic; Naloxone; Neuroprotective Agents; Pregnatrienes; Randomized Controlled Trials as Topic; Spinal Cord Injuries; Treatment Outcome | 1996 |
2 trial(s) available for methylprednisolone and 4-aminopyridine
Article | Year |
---|---|
The effects of taxol, methylprednisolone, and 4-aminopyridine in compressive spinal cord injury: a qualitative experimental study.
Topics: 4-Aminopyridine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Dose-Response Relationship, Drug; Evoked Potentials, Somatosensory; Male; Methylprednisolone; Microtubules; Motor Skills; Paclitaxel; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 1996 |
Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial.
Topics: 4-Aminopyridine; Double-Blind Method; Humans; Methylprednisolone; Multiple Sclerosis; Myelitis, Transverse; Potassium Channel Blockers; Treatment Outcome | 2023 |
4 other study(ies) available for methylprednisolone and 4-aminopyridine
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effect of 4-aminopyridine and single-dose methylprednisolone on functional recovery after a chronic spinal cord injury.
Topics: 4-Aminopyridine; Animals; Behavior, Animal; Chronic Disease; Glucocorticoids; Male; Methylprednisolone; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 1998 |
Neuroscience. Animal studies raise hopes for spinal cord repair.
Topics: 4-Aminopyridine; Animals; Chondroitin ABC Lyase; Clinical Trials as Topic; Combined Modality Therapy; Cyclic AMP; Growth Inhibitors; Growth Substances; Humans; Methylprednisolone; Myelin Proteins; Myelin-Associated Glycoprotein; Nerve Regeneration; Neuroglia; Neurons; Neuroprotective Agents; Nogo Proteins; Olfactory Mucosa; Receptors, Cell Surface; Recovery of Function; Spinal Cord Injuries; Spinal Nerves; Stem Cell Transplantation; Stem Cells | 2002 |
The effects of 4-aminopyridine and methylprednisolone on recovery of the facial nerve crush injury.
Topics: 4-Aminopyridine; Animals; Crush Injuries; Disease Models, Animal; Facial Nerve; Facial Nerve Injuries; Male; Methylprednisolone; Nerve Regeneration; Rats; Rats, Wistar; Recovery of Function | 2021 |